您的购物车当前为空
别名 1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) 是一种选择性 S1P2拮抗剂,可用于特发性肺纤维化的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) 是一种选择性 S1P2拮抗剂,可用于特发性肺纤维化的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 562 | 现货 | |
| 5 mg | ¥ 1,380 | 现货 | |
| 10 mg | ¥ 2,280 | 现货 | |
| 25 mg | ¥ 4,480 | 现货 | |
| 50 mg | ¥ 6,290 | 现货 | |
| 100 mg | ¥ 8,490 | 5日内发货 | |
| 200 mg | ¥ 11,300 | 5日内发货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,790 | 现货 |
GLPG2938 相关产品
| 产品描述 | GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and selective antagonist of S1P2. |
| 体外活性 | GLPG2938在所有测试浓度下显著阻止了S1P介导的收缩[1]。 |
| 体内活性 | 在所有物种中,GLPG2938显示出良好的药代动力学特性,具有长半衰期、低清除率和良好的生物利用度。 |
| 别名 | 1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea |
| 分子量 | 503.4 |
| 分子式 | C20H19F6N7O2 |
| CAS No. | 2130996-00-6 |
| Smiles | CCOc1cc(NC(=O)NCc2cc(C)c(nn2)-c2cn(C)nc2C(F)(F)F)cc(n1)C(F)(F)F |
| 密度 | 1.49 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 60 mg/mL (119.19 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.97 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容